ISPVX
Price
$26.05
Change
+$0.05 (+0.19%)
Updated
Aug 11 closing price
Net Assets
386.47M
VSCPX
Price
$423.28
Change
+$1.38 (+0.33%)
Updated
Aug 11 closing price
Net Assets
183.38B
Interact to see
Advertisement

ISPVX vs VSCPX

ISPVX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
ISPVX vs. VSCPX commentary
Aug 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISPVX is a Buy and VSCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 183B vs. ISPVX (386M). VSCPX pays higher dividends than ISPVX: VSCPX (1.24) vs ISPVX (0.34). ISPVX was incepted earlier than VSCPX: ISPVX (12 years) vs VSCPX (16 years). ISPVX (0.95) is less costly to investors than VSCPX (0.02). ISPVX is a more actively managed with annual turnover of: 22.00 vs. VSCPX (17.00). ISPVX has a lower initial minimum investment than VSCPX: ISPVX (0) vs VSCPX (100000000). ISPVX annual gain was more profitable for investors over the last year : 32.83 vs. VSCPX (27.45). VSCPX return over 5 years is better than : 38.21 vs. ISPVX (4.01).
ISPVXVSCPXISPVX / VSCPX
Total Expense Ratio0.770.023,850%
Annual Report Gross Expense Ratio0.950.024,750%
Fund Existence12 years16 years-
Gain YTD22.00418.477119%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets386M183B0%
Annual Yield % from dividends0.341.2428%
Returns for 1 year32.8327.45120%
Returns for 3 years60.3252.74114%
Returns for 5 years4.0138.2111%
Returns for 10 years49.68160.4031%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOIX91.620.93
+1.03%
Rydex Biotechnology Inv
MRLRX22.180.01
+0.05%
BlackRock Advantage Large Cap Core R
HAMVX34.40-0.03
-0.09%
Harbor Mid Cap Value Instl
VBINX55.16-0.09
-0.16%
Vanguard Balanced Index Inv
MAMEX23.56-0.08
-0.34%
MoA Mid Cap Equity Index Fund